
    
      In this study, the patients with liver cirrhosis will undergo administration of human
      Mesenchymal stem cell MSCs intravenously for these patients.To observe the results Liver
      function will be monitored by serum analysis.The levels of serum alanine aminotransferase
      (ALT), total bilirubin (TB), prothrombin time (PT), prealbumin(PA) and albumin (ALB) will be
      examined at pre-transfusion, and 6th days to 1 years post-transfusion.Also the to see
      Improvement evaluation by MELD score ,Quality of life ,Child-Pugh score will be done .
    
  